This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Dalia Megiddo and Trehalose-Based Treatment Research.
Introduction
Dalia Megiddo is an inventor associated with Israel. The supplied information lists no patents for her, while describing a patent application concerning trehalose-based treatment for diseases involving abnormal protein aggregation.
Latest Patents
The described invention, “Treatment of Protein Aggregation Myopathic and Neurodegenerative Diseases by Parenteral Administration of Trehalose,” proposes treating diseases associated with abnormal protein aggregation by administering pharmaceutical formulations containing trehalose. It also describes an aqueous injectable formulation whose single active ingredient consists essentially of substantially purified trehalose, with less than 0.5% contaminants. The supplied data reports 0 patents for Megiddo, so the invention description should not be taken as confirmation of an issued patent or its current status.
Career Highlights
The supplied information associates Megiddo with Seelos Therapeutics, Inc. and Gld Debt Acquisition 2025-1, Inc. It does not specify her roles or provide further details about her career.
Collaborations
The available information identifies these company associations but does not describe specific research collaborations, co-inventors, or organizational contributions to the trehalose-related invention.
Conclusion
Dalia Megiddo is linked in the supplied information to a proposed trehalose-based approach to protein-aggregation diseases and to two company associations, while her reported patent count is zero.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile